Top compounds associated with response to NELFB


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.023 0.7
mRNA AUY922 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA LFM-A13 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA ML320 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA GSK-1904529A GDSC1000 pan-cancer AAC 0.014 0.7
mRNA lapatinib CCLE pan-cancer AAC 0.018 0.7
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV